Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-04-036815
Filing Date
2004-07-21
Accepted
2004-07-21 16:21:48
Documents
1
Period of Report
2004-07-21

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 4570
  Complete submission text file 0001209191-04-036815.txt   6917
Mailing Address LICHTSTRASSE 35 CH-4002 BASEL V8
Business Address LICHTSTRASSE 35 CH-4002 BASEL V8 212-830-2474
NOVARTIS PHARMA AG (Reporting) CIK: 0001030617 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-49839 | Film No.: 04924607

Mailing Address
Business Address 60 HAMPSHIRE STREET . CAMBRIDGE MA 02139 (617) 250-3100
IDENIX PHARMACEUTICALS INC (Issuer) CIK: 0001093649 (see all company filings)

SIC: 2834 Pharmaceutical Preparations

Mailing Address LICHSTRASSE 35 BASEL SWITZERLAND CH 4056
Business Address LICHSTRASSE 35 BASEL SWITZERLAND V8 CH 4056
NOVARTIS AG (Reporting) CIK: 0001114448 (see all company filings)

Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 000-49839 | Film No.: 04924608
SIC: 2834 Pharmaceutical Preparations